CAJ | 학술논문

以中国转基因水稻审批过程为例,探讨了后常态科学下的中国公共政策决策机制,指出专家委员会的内部咨询模式和技术官僚为主体的内部决策模式存在一定的局限性。之后,对比分析了美国和欧盟的转基因生物管理制度,探索在科学不确定性下公共决策机制的改进方向,即充分的信息公开和广泛的公众参与、政策实施中的审慎预防原则,以及有效的政策纠偏和损害救济机制。
이중국전기인수도심비과정위례,탐토료후상태과학하적중국공공정책결책궤제,지출전가위원회적내부자순모식화기술관료위주체적내부결책모식존재일정적국한성。지후,대비분석료미국화구맹적전기인생물관리제도,탐색재과학불학정성하공공결책궤제적개진방향,즉충분적신식공개화엄범적공음삼여、정책실시중적심신예방원칙,이급유효적정책규편화손해구제궤제。
Based on a case study of the approval process of Genetically Modified Rice,this paper explores China＇ policy decision-making mechanism in an era of post-normal science.It is argued that China＇s internal consulting model of experts committee and the internal decision-making model conducted by the technocrats have some limitations.This is followed by a comparative analysis of the GMOs management system in China,U.S.and EU.Measures to improve China＇s public decision-making mechanism under uncertainty are proposed,including better information disclosure,more extensive public participation,and the precautionary principle in policy implementation,as well as more effective policy correction and damage-control mechanism.